| Original language | English |
|---|---|
| Pages (from-to) | 679-681 |
| Number of pages | 3 |
| Journal | Nature Reviews Neurology |
| Volume | 10 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2014 Dec 11 |
ASJC Scopus subject areas
- Clinical Neurology
- Cellular and Molecular Neuroscience
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Neuroimmunology : Towards more-accurate diagnosis in neuromyelitis optica. / Fujihara, Kazuo; Palace, Jacqueline.
In: Nature Reviews Neurology, Vol. 10, No. 12, 11.12.2014, p. 679-681.Research output: Contribution to journal › Short survey › peer-review
}
TY - JOUR
T1 - Neuroimmunology
T2 - Towards more-accurate diagnosis in neuromyelitis optica
AU - Fujihara, Kazuo
AU - Palace, Jacqueline
N1 - Funding Information: K.F. has received funding from the Grants-in-Aid for Scientific Research form the Ministry of Education, Science and Techonology and the Ministry of Health, Labor and Welfare of Japan. J.P. acknowledges highly specialized funding from NHS England to run a national NMO service. Funding Information: K.F. serves on scientific advisory boards for Alexion Pharmaceuticals, Bayer Schering Pharma, Biogen Idec, Chugai Pharmaceutical, Merck Serono, Mitsubishi Tanabe Pharma Corporation, Nihon Pharmaceutical, Novartis Pharma and Ono Pharmaceutical. He has received travel funding and speaker honoraria from Asahi Kasei Medical Co., Astellas Pharma Inc., Bayer Schering Pharma, Biogen Idec, Cosmic Corporation (a distributer of ELISA to detect aquaporin AQP4-IgG in Japan), Daiichi Sankyo, Eisai Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma and Takeda Pharmaceutical Company, Ltd; and research funding from Asahi Kasei Medical Co., Bayer Schering Pharma, Biogen Idec Japan, Eisai Inc., Kowa Pharmaceuticals America, Inc., Mitsubishi Tanabe Pharma Corporation, Teva Pharmaceutical K.K., Teijin Pharma, and The Chemo-Sero-Therapeutic Research Institute. J.P. has received conference funding for scientific meetings and honoraria for advisory work from Bayer Schering, Biogen Idec, Chugai Pharma, Merck Serono, Novartis, Ono Pharmaceutical Co. Ltd and Teva. She has received unrestricted research grants from Bayer Schering, Biogen Idec, Merck Serono and Novartis. Copyright: Copyright 2016 Elsevier B.V., All rights reserved.
PY - 2014/12/11
Y1 - 2014/12/11
UR - http://www.scopus.com/inward/record.url?scp=84927177495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927177495&partnerID=8YFLogxK
U2 - 10.1038/nrneurol.2014.216
DO - 10.1038/nrneurol.2014.216
M3 - Short survey
C2 - 25385336
AN - SCOPUS:84927177495
VL - 10
SP - 679
EP - 681
JO - Nature Reviews Neurology
JF - Nature Reviews Neurology
SN - 1759-4758
IS - 12
ER -